Thus, albeit initial CD19 positivity and stringent complete responses after CD19-CAR T cell infusion, a sizable portion of patients suffering from B-ALL relapse with CD19-negative blasts [2,7,8]. Here, CD19 is linked to acute lymphoblastic leukemia.